Matthew Groenewold

Dr. Matthew Groenewold

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2017 in American Journal of Industrial Medicine
Verified
Journal Article
Closed access
PDF file
MGMatthew Groenewold
Matthew Groenewold
RSRaymond F.R. Sarmiento
Raymond F.R. Sarmiento
KVKelly Vanoli
Kelly Vanoli
WRWilliam Raudabaugh
William Raudabaugh
SNSusan Nowlin
Susan Nowlin
AGAhmed Gomaa
Ahmed Gomaa


3 April 2014 in American Journal of Industrial Medicine
Verified
Journal Article
Closed access
PDF file
MGMatthew Groenewold
Matthew Groenewold
EMElizabeth A. Masterson
Elizabeth A. Masterson
CTChrista L. Themann
Christa L. Themann
RDRickie R. Davis
Rickie R. Davis

22 July 2021 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Open access
JGJa K Gu
Ja K Gu
PAPenelope Allison
Penelope Allison
ATAlexis Grimes Trotter
Alexis Grimes Trotter
LCLuenda Charles
Luenda Charles
CMClaudia C. Ma
Claudia C. Ma
SLSara E. Luckhaupt
Sara E. Luckhaupt
Objective: To estimate the self-reported prevalence of prescription opioid use and illicit drug use in the United States. Methods: Self-reported prescription opioid use and illicit drug use (mostly nonopioid) were obtained for adults and adult workers (NHANES 2005–2016). Results: Prevalence (95% CI) of prescription opioid use was 6.5% (6.0–7.0) (adults) and 4.1% (3.7–4.5) (workers). Prevalence of illicit drug use was 9.5% (8.8–10.1) (adults) and 10.2% (9.4–11.1) (workers). Among occupations, prevalence of prescription opioid use was highest in personal care (6.5%; 4.1–10.4) and healthcare practitioners (5.9%; 3.8–9.0); for illicit drug use, construction/extraction (18.0%; 15.1–21.3) and food preparation (15.8%; 12.5–19.7). Conclusion: The prevalence of prescription opioid use was elevated among some occupations. Judicious prescription strategies and targeted interventions are both needed. The prevalence of illicit drug use among certain occupational groups suggests the need to ensure access to therapy.

14 April 2022 in American Journal of Infection Control
Verified
Journal Article
Closed access
RBRachael M. Billock
Rachael M. Billock
MGMatthew Groenewold
Matthew Groenewold
MSMarie Haring Sweeney
Marie Haring Sweeney
MPMarie A. de Perio
Marie A. de Perio
DGDenise M. Gaughan
Denise M. Gaughan
SLSara E. Luckhaupt
Sara E. Luckhaupt

14 September 2019 in American Journal of Industrial Medicine
Verified
Journal Article
Closed access
PDF file
MGMatthew Groenewold
Matthew Groenewold
LBLinda Brown
Linda Brown
ESEmily Smith
Emily Smith
MSMarie Haring Sweeney
Marie Haring Sweeney
RPRene Pana‐Cryan
Rene Pana‐Cryan
TSTheresa Schnorr
Theresa Schnorr